Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I see good fundamentals in this company. imo
SignatureOne® Suite
The CIC® enterprise-class SignatureOne Suite of electronic signature solutions enable businesses to implement truly paperless, eSignature-driven, business processes.
Many applications provide electronic forms and allow users to fill in information, but in the end they still print out a paper copy for an ink signature.
CIC enabled solutions go that last mile and allow legally binding electronic signatures to be added to digital documents, eliminating the need for paper copies. Without the need for paper copies, customers can receive feedback faster and have shortened response times. Likewise, enterprises have document storage and retrieval made significantly easier, and more time made available for new prospects—all resulting in lower costs and higher ROI.
The SignatureOne Suite includes:
SignatureOne Ceremony® Server
SignatureOne Profile Server
Sign-it®
iSign®
http://www.cic.com/products/
CIC is a leading supplier of electronic signature solutions within the Financial Services Industry enabling enterprises to fully execute Business Process Automation initiatives that result in truly paperless workflow and legally binding, compliant electronic transactions. That leadership is evidenced by our worldwide deployments at leading financial institutions including such companies as: AIG, Charles Schwab, Prudential Insurance, Nationwide (UK) and Wells Fargo.
CIC’s electronic signature solutions provide the basis for significant expense reduction through document and workflow automation at a much higher level of security. The billions of signed original paper documents created in today’s global economy demand the utmost in user identification and document integrity. The inherent risks, logistical difficulties and staggering financial costs associated with creating, processing, storing, retrieving and delivering paper records are driving the demand for legally binding and secure electronic documents.
Recognizing the need to address electronic signatures from and overall enterprise perspective, The CIC SignatureOne™ Solutions Suite of Sign-it®, SignatureOne Profile Server, and iSign® products provide a common interface and methodology for eSignature based, enterprise-wide, business process automation applications.
http://www.cic.com/solutions/
Good morning
Capitalizing on Unmet Needs in the Specialty
Pharmaceutical Market
Aradigm has redefined its business strategy to independently forge a leading position in the specialty pharmaceutical market. With its highly targeted strategic development efforts, clinical expertise and the strength of a well accomplished leadership force, the company is well positioned to capitalize on niche opportunities for new and improved products used in the treatment of severe respiratory disease. The company will achieve this mission by building on its core expertise and focusing on the following strategic efforts:
• Continued development of proprietary respiratory disease therapies;
• Pursue regulatory pathways that reduce the time, costs and risks associated with product development;
• Conservation of capital for proprietary product development through the outsourcing of late stage clinical and commercial scale manufacturing;
• Deployment of a specialized sales and marketing force to meet the unique needs of pulmonologists and sub-specialists in the United States;
• Out-licensing technology and intellectual property assets for applications that lie outside the company's strategic interests and core expertise.
http://www.aradigm.com/about_bus_over.html
AERx Second-Generation Delivery Device: AERx Essence®
AERx Essence is a small, palm-size all-mechanical device. The AERx Essence system offers a level of performance (efficiency and reproducibility) close to the first generation AERx system, but in a small, light and low-cost package, yet retaining the high durability of the first generation systems.
AERx First-Generation Hand-Held Delivery Devices
AERx first-generation inhalation delivery systems are sophisticated electromechanical devices that were designed to achieve superior efficiency and precision required for applications such as Type 1 and Type 2 diabetes management with inhaled insulin, represented by the product AERx iDMS previously licensed to our partner Novo Nordisk. The first-generation devices include the two examples shown below. The first device is for diabetes management. It features dose titration capability to one unit, inhaled air temperature and flow control as well as electronic disease management capabilities. The second device has similar features to the AERx iDMS but is for pain management. Next to the device, the photograph shows the user and prescriber electronic keys to prevent misuse and abuse of controlled drug substances.
Estimated Market Cap
$20,857,974 as of Dec 10, 2008
Outstanding Shares
32,089,190 as of Aug 13, 2008
Number of Share Holders of Record
578 as of Mar 31, 2008
http://www.pinksheets.com/pink/quote/quote.jsp?symbol=payi
Key Points
Key Points
Pay88 is the leading reseller of online multiplayer game time in Chongqing, China
Successfully captured 80% distribution of the online multiplayer game time through retail kiosks
and Internet Cafés in Chongqing and is poised to physically expand into other cities where they are
already selling through their online platform
Currently distributes online multiplayer game time and prepaid game cards for over 600 online
multiplayer games and has exclusivity agreements in Chongqing with 8 different companies for over
50 different games
Exclusively distributes online game time and cards for major game operators including Shanda
Entertainment (Nasdaq: SNDA) - net revenue in 2006 of $211.9 M USD. According to Pacific Epoch’s
April 2007 Company Intelligence Report, Shanda Entertainment is still China’s most recognized
online game company and Pay88 has exclusive distribution rights in Chongqing for approximately
20 of Shanda’s online multiplayer games including the very popular Legend of Mir 2
The reselling online multiplayer game time has generated the highest revenue stream and offers
huge long-term potential
China is predicted to be home to a $2.1 billion game industry by 2010 according to research &
consultancy firm, Niko Partners
Well positioned to capitalize on this growth opportunity by reselling of online multiplayer game time
to consumers via its online virtual mall and its established distribution network in Chongqing, China
(pop. +31M)
Pay88 also distributes prepaid telephone cards for the major Chinese telecom giants (China Mobile,
China Unicom and China Telecom) and hopes to capture a portion of the market of the
approximately 200 million prepaid phone card users
State-of-the-art technology and licensing agreement which enables Pay88 to directly withdraw funds
from 19 different banking institutions
Pay88 is one of only 30 companies in China that is capable of operating the online payment platform
which enables the online withdrawal of funds
Reseller agreements in place for distribution of products on their virtual mall www.iamseller.com
http://www.pay88.com/english/New%20Folder/PAYI2_factsheet2.html
I thnk there are great fundamentals here..imo
Market Potential
Largest, fastest growing Internet economy
The online market potential is in its infancy with 25 % of China’s online population depending on
Internet Cafés as an online access point
With the proliferation of Internet access in China, there will be a huge spike in all Internet related
areas of commerce
Gaming companies like The9 rely heavily on distribution networks like Pay88’s for the sale of their
game playing time and game cards to end users
The prepaid market in China is expected to surpass the prepaid market in the US where $290 B
USD in goods and services were spent in 2006
Latest PR
Australian-Canadian Oil Royalties Gives an Update on Recent Events
Wednesday December 3, 9:01 am ET
CISCO, Texas--(BUSINESS WIRE)--Australian-Canadian Oil Royalties Ltd. (herein called ACOR) (OTCBB:AUCAF) is pleased to announce that the company has recently purchased an ORRI under VIC/P59 in the Gippsland Basin. The operator of VIC/P59 is Apache Energy Limited.
ADVERTISEMENT
Apache Energy is currently moving the rig to begin drilling the Madfish-1 exploration well in the offshore Gippsland Basin, targeting possible mean reserves of approximately 33.6 - 41.7 million barrels of oil.
This well in VIC/P59 will be drilled by the Ocean Patriot semi-submersible drilling rig. The Madfish-1 well will be followed by the Elver-1 prospect that will target possible mean oil reserves of approximately 39.5-51.3MMbbl respectively.
The Madfish-1 well is located in about 1279 feet of water and has a planned total depth of approximately 9,284 feet while the Elver-1 prospect has a planned total depth of approximately 10,334 feet.
About VIC/P59
VIC/P59 consists of 301,468 gross acres and is located offshore in the Gippsland Basin. VIC/P59 is adjoined by the Blackback Oil Field with estimated reserves of 80,000,000 barrels of oil.
About The Gippsland Basin:
In excess of 4 billion barrels of oil/condensate and 12 TCF gas reserves have been discovered in the Basin since exploration drilling began in 1964, with remaining reserves estimated at 600 million barrels of oil and 5 trillion cubic feet of gas. Current production of the Basin is around 140,000 barrels per day of crude and 570 million cubic feet per day of gas. At peak rates, the Gippsland Basin can deliver more than 1,000 million cubic feet a day.
Some of the very best oil production in the world is found in the Gippsland Basin.
Click on link below to see a map of VIC/P59.
http://www.aussieoil.com/site/acor-map.htm
ACOR owns a 1/20th of 1% ORRI under VIC/P59.
PEL 112 Update
The Cooper/Eromanga Basin’s western margin had been more or less written off, but a handful of companies are turning it into a bustling oil province.
Companies such as Beach Petroleum, Cooper Energy, Stuart Petroleum, Victoria Petroleum & ACOR that took up Cooper/Eromanga Basin western margin acreage remain optimistic about the region’s potential.
Victoria Petroleum states: “The typical model is gas generation in the middle of the basin pushing oil out towards the margins.”
Victoria Petroleum states: “In the US, people would have been drilling the edges, but we have done it backwards in Australia.”
In PEL 92 block, Cooper Energy states: “Cooper Energy and Beach [the operator] have discovered five oil fields and have an exploration success rate of 45 per cent,” “But since switching from 2D to 3D seismic, Cooper and Beach [the operator] have had a 100 per cent drilling success rate demonstrating that the oil migration risk is relatively low and the structural risk is being addressed by the application of new technology.”
PEL 92 has proved to be an astounding success story. Sellicks was followed by Christies (2003), Silver Sands (2006), Callawonga (2006) and Parsons (2007).
Cooper Energy states: “The completion of the Parsons high volume artificial lift project alone is expected to boost the PEL 92 joint venture production to approximately 6000 barrels of oil per day, subject to downstream production constraints.”
PEL 92 is North of ACOR’s PEL 112.
Holloman Energy Corporation (OTC BB:HENC.OB - News) has announced this year that Holloman Energy is beginning a drilling program of shallow test wells (200m) on its Australian Petroleum Exploration Lease (PEL) 112, to confirm the location of physical structures identified by seismic data.
This shallow drilling is in advance of a multi-well drilling program with total depths to approximately 6,500 feet, and is expected to start late in the fourth quarter of 2008 to early 2009.
On advice of Holloman Energy’s Australian based technical consultants, a recommendation has been made that Holloman Energy first drill “Up-hole” tests at key strategic points on the specific seismic lines which have been used to define the target structures. The results from these Up-hole tests will be used to fine tune the exploration well locations.
Up-hole tests, while not required, are not uncommon in this part of the Cooper Basin due to a surface layer of thick sand dunes. Upon completion of these Up-hole tests, pending successful outcomes, Holloman Energy will apply for drilling permits from the Australian Government.
The proposed well locations are located in the upper panhandle portion of the Company's 554,000 acre PEL112 concession in Australia's prolific Cooper Eromonga Basin.
ACOR owns a 13.83% carried W.I. in the next 2 wells under PEL 112 and then ACOR will pay its proportionate part for future exploration cost.
New Oil Field Discovery on ACOR’s ORRI under PEL 111
ACOR is pleased to announce that the operator, Victoria Petroleum N. L. has stated that the Warhawk-1 well was completed for production on ACOR’s ORRI under PEL 111 located in the prolific Cooper/Eromanga Basin in South Australia.
Victoria Petroleum N. L. advises that the Warhawk-1 exploration well has been completed for production with the running and cementing of 7 inch casing to a total depth of 1,868 metres.
During the drilling of Warhawk-1, oil shows were observed over the gross interval of 1,729-1,748 meters in the target Birkhead Sandstone. Initial analysis of the wire line logs indicated that the Birkhead Formation reservoir section is oil bearing but that the reservoir section is not as well developed as encountered in several of the Growler oil wells in the Growler Oil Field, 10 kilometers to the south.
Several attempts to open hole test the Birkhead oil zone with straddle drill stem tests were made, but were unsuccessful due to equipment failure. A wire line pressure and sampling program was then carried out and confirmed the presence of thin permeable oil bearing sandstones within the Birkhead Formation.
The PEL 111 Joint Venture has elected to complete the well for future production.
ACOR owns a 1/10th of 1% ORRI under PEL 111.
About Australian-Canadian Oil Royalties Ltd.:
ACOR management draws no cash salary. ACOR has NO LONG-TERM DEBT. ACOR's principal assets consist of 15,440,116 gross surface acres of overriding royalty interest and 8,561,007 gross acres of working interests, located Onshore Australia in the Cooper-Eromanga Basin and Offshore Australia in the Gippsland Basin in the Bass Strait and Offshore in the Carnarvon Basin in Western Australia.
ACOR is a publicly traded oil company trading on the NASDAQ OTC Bulletin Board Exchange under the trading symbol "AUCAF." Our stock price has doubled in the last seven days!
Summary:
Australia is a "hot spot" for oil & gas exploration and ACOR is positioned for possible "Company-Maker" discoveries. ACOR's working interests and overriding royalty interests are located offshore & onshore in the best producing basins.
Visit our website at www.aussieoil.com.
Disclaimer:
Except for historical information contained herein, the statements released are forward-looking statements that are made pursuant to the provision of the Private Securities Litigation Reform Act of 1955. Forward-looking statements involve known and unknown risks and uncertainties that may cause the Company's actual results in future periods to differ materially from forecasted results. Such risks and uncertainties include, but are not limited to, market conditions, competitive factors, the ability to successfully complete additional financings and other risks.
Contact:
Australian-Canadian Oil Royalties Ltd.
Investor Relations, 254-442-2638
acor@classicnet.net
http://biz.yahoo.com/bw/081203/20081203005149.html?.v=1
Australian-Canadian Oil Royalties Ltd. principal assets consist of 15,440,116 gross surface acres of overriding royalty interest and 8,561,007 gross acres of working interests, located Onshore Australia in the Cooper/Eromanga Basin & Offshore Australia in the Gippsland Basin.
ACOR is currently engaged in the acquisition, development, production, and marketing of Oil & Gas in Australia. ACOR is an Canadian Corporation incorporated in Vancouver, British Columbia in 1997.
Estimated Market Cap
$1,236,772 as of Dec 9, 2008
Outstanding Shares
13,741,912 as of Apr 8, 2008
Number of Share Holders of Record
322 as of Apr 14, 2008
http://pinksheets.com/pink/quote/quote.jsp?symbol=aucaf
What is Interoperability?
Interoperability is a term used to describe the joining of different modes of communication that, in the past, were not compatible. Modern communications technologies allow traditional telephones, land mobile radios, push-to-talk phones, cellular phones, voice-over-IP phones, and soft consoles running on personal computers to interoperate or exchange voice and data messages seamlessly. VoiceInterop specializes in designing and building interoperable systems that enhance your communications.
Why is it important?
As the worldwide shift to IP based technologies continues, it provides protection against technological obsolescence for people and devices to interoperate together today and well into the future.
http://www.voiceinterop.com/info/faq.htm
imo
Saving money is substantial to today's consumers. With VoiceInterop, unified communications is a value-added proposition to existing communication products and services. By augmenting your existing communications with interop technology, businesses and government can alike improve their operational efficiencies regardless of geographic location.
imo
They have a great approach with developing communication applications especially with organizations in the public and private sectors. I think we shall see very beneficial results from this company.
imo
Came across VoiceInterop a few months back. I am very impressed with their products and services. I see great fundamentals and will definietly keep my eye on this company in the time to come.
imo
After reading the latest PR, it is good to see they are getting ready for the upcoming tax season by presenting different strategies to further educate attendees of the Workshop. imo
Whats going on with Chad? Still waiting.......
Joel Logan - President
Steve Lawler - Director of Finance, Secretary, Treasurer
Chet Murphree - Vice President/ Sales Manager
Deer Valley Homebuilders, StoneBridge Series is focused on modular buildings and developments. This series consists of single-family homes, 1-2 family homes, and townhouses.
Deer Valley Homebuilders, Inc. is located in Guin and Sulligent, Alabama. Deer Valley Homebuilders, Inc products are available through retail sales centers in Alabama, Arkansas, Florida, Georgia, Illinois, Indiana, Kansas, Kentucky, Louisiana, Missouri, Mississippi, Oklahoma, Tennessee, Texas, and West Virginia.
good morning
Corporate Office
1000 Industrial Way North,Suite C
Toms River, NJ 08755
Phone:732-281-1355
Fax: 732-281-1365
Toll Free:877-323-CCTV
www.vmscctv.com
Manufacturing Facility
8220 Washington Village Dr.
Centerville,OH 45458
Toll Free:937-438-8400
Fax: 732-281-1365
www.vmspdg.com
Company's PR's - http://www.vmscctv.com/news.php#
Cost- Because VMS is a “Full-Spectrum” provider; we are able to compete with virtually any organization or service provider on a price basis. We design our own software, complete sub-assembly and OEM manufacturing, install and service our own systems and in some instances, finance the same.
Process- VMS markets Loss Prevention. We begin with a dedicated, in-house telemarketing effort to support our highly trained and dedicated sales force. Our marketing message is results oriented and we offer an ROI focused, proactive system with training and instruction materials.
People- The VMS management team brings experience from small, medium and large businesses and from a range of complimentary industries. There is no better group of people to deliver this product and service to the market.
Customer Service- We offer our customers live, remote assistance as well as training, software upgrades and installation in real time. We offer toll-free tech support hotlines. One service technician can support more than 500 installed clients when paired with the tech support desk and the remote live assistance.
http://www.vmscctv.com/why.php
Company's SEC filings - http://www.vmscctv.com/sec.php
I agree with what is previously posted in the ibox, that there is no other company like this.
imo
VMS offers a full range of protective technology products and services to a host of businesses and industries. Professional Loss Prevention consultants, System Design specialists, CCTV installers and technical support agents are available to assist our customers with all aspects of system design, ownership and usage and maximizing the value of a professional remote management system.
Visual Management Systems Holding (VMSH) is a New Jersey Based Corporation that provides businesses with remote management systems for loss prevention, physical security, asset protection, and management controls – on and off-site.
Corporate Profile - Mediscience Technology Corporation is successfully engaged in the design and development of diagnostic medical devices that detect cancer using light induced native tissue fluorescence spectroscopy to distinguish between malignant and normal or benign tissue.
Corporate Headquarters
1235 Folkstone Way
Cherry Hill, New Jersey 08034
Telephone: 856-428-7952
Fax: 215-763-2908
Corporate Officers
Peter Katevatis Esq., Chairman and CEO
Key Personnel
Peter Katevatis Esq., Chairman and CEO
Peter Katevatis has served as Chairman of the Board of Directors since 1993. He is a practicing attorney admitted to the Pennsylvania, New York, New Jersey and the Washington DC bar associations.
Mr. Katevatis served as fiduciary trustee of the New Jersey Police and Firemans Fund and as a member of the New Jersey State Investment Council from 1990 to 1993. In that capacity, he participates in the fiduciary investment and oversight of all New Jersey state pension funds totaling approximately 50 billion dollars.
He serves as a judicial arbitrator for the American Arbitration Association and the National Association of Securities Dealers (NASD). Mr. Katevatis is also a long-time member of the National District Attorney's Association.
Frederick Naftolin, MD, PhD
Chairman of Scientific Advisory Board (Mediscience Technology)
Frederick Naftolin, MD, PhD is a Professor for the Department of Obstetrics and Gynecology at New York University School of Medicine. He was the former Chairman Emeritus of the Department of Obstetrics, Gynecology and Reproductive Sciences, Professor of Obstetrics, Gynecology and Reproductive Sciences and of Molecular, Cellular and Developmental Biology, for Yale University.
Dr. Frederick Naftolin obtained his medical degree from University of California, School of Medicine, San Francisco and his doctoral degree from Oxford University. In addition to his considerable clinical experience, Dr. Naftolin has long been an NIH-funded researcher in the areas of reproductive endocrinology and oncology. His work is on the cell- and molecular biology that surround these areas. Dr. Naftolin has been a Guggenheim Scholar, an NIH Fogarty Fellow (X2), and a Berlex International Scholar. Under the aegis of these awards, he has performed research and teaching as a Visiting/Special Professor at the University of Geneva, the Complutensa University and Instituto Cajal (Madrid) and the Weizmann Institute of Technology. Dr. Naftolin is the author of more than 600 original publications and reviews, has edited 12 books and is an editor/associate editor of three journals. He has been honored by the Arnaldo Bruno Prize of the Italian Academy (Lincei) in 2002 and the President's Distinguished Scientist Award of the Society for Gynecological Investigation in 2003. Dr. Naftolin is currently on the Executive Board of the International Menopause Society and the Society for Experimental Biology and Medicine.
Research and Development - The potential utility of native tissue fluorescence spectroscopy for in vivo cancer detection in humans was first discovered by Professor Robert R. Alfano, Distinguished Professor of Physics and Engineering at the City College of the City University of New York (CUNY).
Mediscience Technology, CUNY, and the Research Foundation of CUNY established the Mediphotonics Laboratory (MPL) at CUNY to provide research and development services in the area of tissue spectroscopy, cancer detection, and other biological applications.
The staff of MPL, supervised by Dr. Alfano, developed our current CD prototype devices. MPL was instrumental in developing our company's latest technological breakthrough in medical imaging, the Stokes Shift Emission Spectroscopy method. When comparing the effectiveness of the Stokes Shift Emission Spectroscopy (SS) method with conventional fluorescence spectroscopy, it is emphatically clear that the SS method is significantly more selective, providing a more effective means of distinguishing cancerous from normal tissue.
MPL also piloted in vitro, pre-clinical testing of various human tissue types such as breast, cervical, colon, and the upper aerodigestive tract. The goal was to develop the preferred optical scanning and emission wavelengths that yield the most definitive information about the native fluorescence characteristics of specific scanned tissue.
The insight gained from this research has been the principal source of knowledge for the company's subsequently issued and pending patents. These patents are either owned outright or components of the company's worldwide exclusive license, highly regarded as pioneering, blocking, and dominant in the area of cancer diagnosis using fluorescence.
Moreover, numerous scientific papers published in peer-review journals and scientific symposia presentations were derived from the research.
Finally, the MPL in vitro preclinical research and development provided the foundation for Mediscience Technology's optical scanning parameters for in vivo human clinical studies.
Product Overview - Creating cutting edge medical devices, Mediscience Technology is a multifacited medical research and development company combining several fields of science and medicine.
Three prototype products employing the company's technology for cancer diagnosis have been developed. They include the cancer detection (CD) CD Scan, CD Ratiometer, and CD Map.
Using lamp light, these devices provide a broad spectrum of safe, scanning excitation light wavelengths to ensure that the appropriate target tissue molecules fluoresce sufficiently to provide maximum diagnostic sensitivity. A fiberoptic probe is attached to each device: the transmission of the optical excitation signal to retrieve the native fluorescence response.
We believe that our CD instruments embody extensive versatility and a broad range of potential alternative applications depending on the preferred configuration of the fiberoptic probe.
For example, the fiberoptic probe can be configured as a convenient hand held probe for easy-to-access areas such as the oral cavity or the skin surface. The optical fiber can be fed down the working channel of:
rigid or flexible endoscopesfor assessment of the upper or lower GI tract
cystoscopes for study of the urinary tract
colposcopes for gynecological evaluation
laparoscopes for evaluation of internal organs
core biopsy needles to optically assess breast tumors or other deep tissue tumors, such as sometimes occur in the pancreas, liver or prostate.